Indian Pharmaceuticals Industry
Govt notifies incentive scheme for local API manufacturing to cut imports
We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO
MPs ask govt to promote inexpensive drugs, tighten reins on pharma lobby
Pharma industry steps up to cure black marketing of Covid-19 drugs
Govt working to select locations for bulk drug, medical device parks

Pharma SMEs will overcome short-term disruptions: CRISIL SME Tracker
Covid-19 crisis: Race to develop vaccine gets a booster as field widens
KKR to acquire controlling stake in JB Chemicals for Rs 3,750 crore
Policy flip-flops may puncture India's image as 'pharmacy of the world'
Covid-19 crisis: Health care workers may get vaccine after phase 2 trials

Relief for pharma firms as govt starts clearing API imports from China
Shot of Hope: Equal access a hurdle after race to coronavirus vaccine
Cadila-CSIR's sepsis drug shows promise in fight against Covid-19
Galwan clash: Govt looks beyond China to source APIs amid Covid-19 crisis
Covid-19 crisis: Made-in-India remdesivir may come by end of June
Covid-19 crisis: Gilead working on combo of remdesivir, other drugs
Covid-19 crisis: Drug sales in May down 9%, fiscal growth to be flat
Amidst controversy, Indian companies continue to manufacture HCQ
Covid-19 crisis: Indian drug companies yet to get nod to market remdesivir
30 groups in India working on coronavirus vaccine, 20 at 'good pace'